Literature DB >> 23023368

Elevation of plasma high-density lipoproteins inhibits development of experimental abdominal aortic aneurysms.

Evelyn Torsney1, Grisha Pirianov, Nicoletta Charolidi, Azza Shoreim, David Gaze, Slaveia Petrova, Ken Laing, Trevor Meisinger, Wanfen Xiong, B Timothy Baxter, Gillian W Cockerill.   

Abstract

OBJECTIVE: Patients with abdominal aortic aneurysms have lower concentrations of high-density lipoproteins (HDLs), leading us to investigate whether increasing plasma HDLs could influence aneurysm formation. METHODS AND
RESULTS: Using the angiotensin II-induced hypercholesterolemic and the CaCl(2)-induced normocholesterolemic mouse model of AAA, we investigated the hypothesis that elevation of HDLs inhibits AAA. HDLs elevated before or at the time of AAA induction reduced AAA formation in both models but had no effect on early ruptures. Analysis of protein lysates from specific aortic segments demonstrated site-specific effects of HDLs on early signal transduction and cellular attrition. We found that HDLs reduced extracellular signal related kinases 1/2 activation in the suprarenal segment, while having no effect on p38 mitogen-associated protein kinase activation in any aortic segment and inhibiting c-Jun N-terminal kinase activation in all aortic segments. In addition, HDL elevation inhibited angiotensin II-induced apoptosis while inducing autophagy in the suprarenal segment of the aorta. Using Illumina gene array profiling we investigated the ability of HDL to modulate basal suprarenal aortic gene expression.
CONCLUSIONS: Increasing plasma HDLs inhibit experimental AAA formation, independent of hypercholesterolemia via reduced extracellular signal related kinases 1/2 activation and alteration of the balance of cellular attrition. HDLs modulate genes involved in matrix remodelling, cell migration, and proliferation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023368     DOI: 10.1161/ATVBAHA.112.00009

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3).

Authors:  Helena Kuivaniemi; Natzi Sakalihasan; Frank A Lederle; Gregory T Jones; Jean-Olivier Defraigne; Nicos Labropoulos; Victor Legrand; Jean-Baptiste Michel; Christoph Nienaber; Marc A Radermecker; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2013-06-01

2.  Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture.

Authors:  Anil Can; Victor M Castro; Dmitriy Dligach; Sean Finan; Sheng Yu; Vivian Gainer; Nancy A Shadick; Guergana Savova; Shawn Murphy; Tianxi Cai; Scott T Weiss; Rose Du
Journal:  Stroke       Date:  2018-04-05       Impact factor: 7.914

3.  Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.

Authors:  Jing Liu; Hong Lu; Deborah A Howatt; Anju Balakrishnan; Jessica J Moorleghen; Mary Sorci-Thomas; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

Review 4.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

Review 5.  High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.

Authors:  Scott M Gordon; Alan T Remaley
Journal:  Atherosclerosis       Date:  2016-11-16       Impact factor: 5.162

6.  Increased Expression of Lamin A/C Correlate with Regions of High Wall Stress in Abdominal Aortic Aneurysms.

Authors:  Amir Malkawi; Grisha Pirianov; Evelyn Torsney; Ian Chetter; Natzi Sakalihasan; Ian M Loftus; Ian Nordon; Christopher Huggins; Nicoletta Charolidi; Matt Thompson; Xie Yun Xu; Gillian W Cockerill
Journal:  Aorta (Stamford)       Date:  2015-10-01

7.  Angiotensin II induces region-specific medial disruption during evolution of ascending aortic aneurysms.

Authors:  Debra L Rateri; Frank M Davis; Anju Balakrishnan; Deborah A Howatt; Jessica J Moorleghen; William N O'Connor; Richard Charnigo; Lisa A Cassis; Alan Daugherty
Journal:  Am J Pathol       Date:  2014-07-16       Impact factor: 4.307

8.  SEPP1 gene variants and abdominal aortic aneurysm: gene association in relation to metabolic risk factors and peripheral arterial disease coexistence.

Authors:  Ewa Strauss; Grzegorz Oszkinis; Ryszard Staniszewski
Journal:  Sci Rep       Date:  2014-11-14       Impact factor: 4.379

Review 9.  Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.

Authors:  Jose Luis Martin-Ventura; Raquel Rodrigues-Diez; Diego Martinez-Lopez; Mercedes Salaices; Luis Miguel Blanco-Colio; Ana M Briones
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

10.  Macrophage Cholesterol Efflux Downregulation Is Not Associated with Abdominal Aortic Aneurysm (AAA) Progression.

Authors:  Marina Canyelles; Mireia Tondo; Jes S Lindholt; David Santos; Irati Fernández-Alonso; David de Gonzalo-Calvo; Luis Miguel Blanco-Colio; Joan Carles Escolà-Gil; José Luís Martín-Ventura; Francisco Blanco-Vaca
Journal:  Biomolecules       Date:  2020-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.